Lingsong Meng1, Xin Zhao1, Jinxia Guo2, Lin Lu1, Qingna Xing1, Yafei Guo1, Honglei Shang1, Penghua Zhang1, Yongbing Sun1, and Xiaoan Zhang1
1The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China, 2MR Research, GE Healthcare, Beijing, China
Synopsis
Early
detection and accurate characterization can reduce significantly the death
rates of breast cancer patients. Kaiser score (KS) demonstrates robust and
wonderful performance in the assessment of breast lesions. Nevertheless, this
scoring system lacks quantitative parameters, which may lead to false
negatives, especially for breast cancers exhibiting atypical morphological
features. In this study, the quantitative value from Synthetic MRI was added to
the KS assessment to improve the differentiation of the malignant and benign
breast lesions.
Introduction and purpose
Adding
the quantitative synthetic relaxation times to Kaiser score (KS) may improve
the diagnostic performance in the assessment of breast lesions. The aim of this
study was to evaluate the differentiation performance with the combination of synthetic MRI (SyMRI) and KS for malignant and benign breast lesions.Materials and Methods
122
patients with 122 breast lesions (86 malignant and 36 benign) were included.
All patients (mean age, 46.6 ± 11.6 years; age range, 18-68 years) underwent
conventional MRI and SyMRI followed by DCE-MRI (SIGNA Pioneer 3T, GE
Healthcare, USA). The SyMRI was acquired with TR/TE1/TE2:
7079msec/23msec/115msec, FOV: matrix: 36cm×36cm.
The
real and imaginary images of SyMRI were imported to SyMRI 11.0 software
(Synthetic MR, Linköping, Sweden) to generate quantitative parametric maps (T1,
T2, and PD maps) for further analysis. The quantitative values including T1,
T2, and PD of the lesions were calculated by using the open-source software
ITK-SNAP (http://www.itksnap.org/pmwiki/pmwiki.php, version 3.8). All lesions
were assigned one score by using the KS system according to the study [1-3]. In this study, the lesions with high KS
categories (threshold > 4) were diagnosed as malignant. If not, the lesions were
diagnosed as benign [4].
All
data were analyzed with the statistical software SPSS 26.0 (IBM) and MedCalc
19.8 (MedCalc Software). After the normality and homogeneity of variances were
examined the quantitative SyMRI parameters (T1, T2, and PD) and KS in malignant
and benign lesions were compared by using the independent sample t-test
or Mann-Whitney U-test. Parameters identified to be significant after
univariate analysis were conducted multivariate analysis (binomial logistic
regression analysis) in further. The receiver operating characteristic (ROC)
analysis was used to evaluate the diagnostic performance to differentiate
malignant from benign lesions. The areas under the ROC curves (AUCs) were
compared by using the Delong test. The optimal threshold, sensitivity,
specificity, and accuracy were obtained at the largest Youden index. P
< 0.05 was considered statistically significant.Results
The
KS of malignant lesions was significantly higher than that of benign lesions (P
< 0.001). The diagnostic accuracy of the application of KS (cutoff = 4) was
88.5% (108/122) (Table 1). With Univariate analysis, significantly lower values were
found in malignancy than in benign lesions for T1 (1398.97 ± 393.14 msec vs.
1968.88 ± 467.49 msec), T2 (85.95 ± 24.24 msec vs. 108.46 ± 29.49 msec), while
there was no significant difference for PD. Clinical examples are provided in Figures
1-2. Multivariate analysis demonstrated that the T1 was the independent
prediction factor for the risk of lesion malignant (P = 0.016) (Table 2). The ROC
analysis showed the AUC of T1 (AUC = 0.827) was slightly lower than that of KS
(AUC = 0.846, P = 0.677). The combination of T1 + KS demonstrated the
optimal performance with AUC of 0.919, which was significantly higher than T1
(AUC = 0.827, P = 0.006) and KS (AUC = 0.846, P = 0.010). The T1
cutoff value that best distinguished malignant and benign breast lesions was
1595.94 msec. The sensitivity, specificity, and accuracy of the T1 + KS were 97.7%,
86.1%, and 94.3%, respectively (Table 3). Discussion
Kaiser
score (KS) puts the independent diagnostic BI-RADS lexicon criteria into an intuitive
machine-learning flowchart to grade the breast lesion in much more detail. The
KS has the potential to provide higher diagnostic accuracy as well as a better
inter-reader agreement in comparison with the BI-RADS lexicon [5; 6].
SyMRI
with magnetic resonance imaging compilation (MAGiC) is a recently proposed
multi-dynamic multi-echo (MDME) sequence, which can simultaneously generate the
quantitative T1, T2, and PD maps in clinically acceptable acquisition time.
The quantitative
T1 and T2 are relaxation properties of tissues, which depend on the tissue
components and structure, correlating with the tissue water and fat content,
macromolecules concentration, and hydration state [7; 8]. With various microstructural alterations
in malignant or benign lesions, the T1 and T2 values might change in a
different way or degree. The mean T2 values for benign lesions (108.46 ± 29.49
msec) were found higher than those for breast cancers (85.95 ± 24.24 msec) (P
< 0.001). This was in line with previous studies and the quantitative values
were at the same level [9; 10]. We found
that the mean T1 values of benign breast lesions (1968.88 ± 467.49 msec) were
significantly higher than that of breast cancers (1398.97 ± 393.14 msec) (P
< 0.001) as the same with prior reports [11;
12] while Gao et al also showed higher T1 in benign lesions but not
significantly [10].
Better
differentiation performance yielded in our study when combining SyMRI parameter
T1 and KS than every single parameter. The AUC of the T1+KS significantly
increased and the specificity also increased by 11.1% in comparison with the KS
alone. What’s more, adding the T1 to the KS assessment obtained better
diagnostic performance (AUC = 0.919) than the prior
study with combined T1 and BI-RADS (AUC = 0.831) [13], further proving the advantage
of KS in comparison with BI-RADS.Conclusion
A
combination of SyMRI and KS holds the potential to improve the accuracy of
diagnosis of benign and malignant lesions.Acknowledgements
The
authors thank the support from the staff in the radiology department of The
Third Affiliated Hospital of Zhengzhou University.References
[1] Dietzel M, Baltzer PAT. How to use the Kaiser score as a clinical decision rule for diagnosis in multiparametric breast MRI: a pictorial essay. Insights Imaging. 2018;9(3):325-335.
[2] Wengert GJ, Pipan F, Almohanna J, et al. Impact of the Kaiser score on clinical decision-making in BI-RADS 4 mammographic calcifications examined with breast MRI. Eur Radiol. 2020;30(3):1451-1459.
[3] Dietzel M, Krug B, Clauser P, et al. A Multicentric Comparison of Apparent Diffusion Coefficient Mapping and the Kaiser Score in the Assessment of Breast Lesions. Invest Radiol. 2021;56(5):274-282.
[4] Milos RI, Pipan F, Kalovidouri A, et al. The Kaiser score reliably excludes malignancy in benign contrast-enhancing lesions classified as BI-RADS 4 on breast MRI high-risk screening exams. Eur Radiol. 2020;30(11):6052-6061.
[5] Kim SJ, Morris EA, Liberman L, et al. Observer variability and applicability of BI-RADS terminology for breast MR imaging: invasive carcinomas as focal masses. AJR Am J Roentgenol. 2001;177(3):551-557.